"This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and ...

A California company has created a first-of-its-kind eyedrop that corrects a certain type of vision impairment and could ...

LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness. This regulatory milestone ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

Reading glasses might be the next thing to go the way of the flip phone. The FDA just approved VIZZ, a once-daily eye drop that helps you see up close without glasses. That’s a big deal if you’re over ...

The FDA approved Vizz for the treatment of presbyopia in adults, according to a press release from Lenz Therapeutics.Once-daily Vizz (aceclidine ophthalmic solution 1.44%) contracts the iris ...

Vizz (aceclidine), is an eye drop designed to help people who have presbyopia, which is a decline in your eye's ability to focus clearly on things close to you. Things at a distance may or may not ...

The cost of VIZZ will be $79 a month for 25 doses, or for a three-month supply of 75 doses, it will be $198, through online pharmacy site UpScript, LENZ said. The drops will also be available at ...